SUBJECTS : Cancer Research | Clinical Oncology | Cancer Genetics | Molecular Targets | Surgical Oncolog
Frontiers in Oncology: 2023, vol: 13, issue:
- 1)- Kyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, Brinda Balasubramanian, Simran Venkatraman, John Gordan, Abed M Zaitoun, Abhik Mukherjee, Arvind Arora, Noppadol Larbcharoensub, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Tavan Janvilisri, Dhanny Gomez, Anna M Grabowska, Rutaiwan Tohtong, David O Bates, Kiren Yacqub-Usman. Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma. Frontiers in oncology. 2023, 13: 1184900
Cited : 1Read More - 2)- Selene Cipri, Francesco Fabozzi, Giada Del Baldo, Giuseppe Maria Milano, Luigi Boccuto, Andrea Carai, Angela Mastronuzzi. Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases. Frontiers in oncology. 2023, 13: 1235794Cited : 0Read More
- 3)- Jun Wang, Zhong-Zheng Xiang, Chen-Feng Tan, Yuan-Yuan Zeng, Tian Yang, Xiao-Yuan Wei, Si-Ting Yu, Ze-Lei Dai, Ning-Yue Xu, Lei Liu. Individualized 3D-printed bolus promotes precise postmastectomy radiotherapy in patients receiving breast reconstruction. Frontiers in oncology. 2023, 13: 1239636Cited : 0Read More
- 4)- Yiping Xin, Qi Zhang, Xinyuan Liu, Bingqing Li, Tao Mao, Xiaoyu Li. Application of artificial intelligence in endoscopic gastrointestinal tumors. Frontiers in oncology. 2023, 13: 1239788Cited : 1Read More
- 5)- Lu Ye, Fei Zhou, Dongdong Cheng, Ming Xie, Xiaoli Yan, Yuyu Xue, Qian Yang, Rong Jia, Lili Zhong, Li Yang, Liqun Zou, Na Huang. Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Frontiers in oncology. 2023, 13: 1240318Cited : 1Read More
- 6)- Ranodeep Chatterjee, Aditya Shukla, Kausiki Chakrabarti, Urmi Chatterji. CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation. Frontiers in oncology. 2023, 13: 1242432Cited : 2Read More
- 7)- Shijie Jin, Liyi Wu, Zhen Liang, Weigang Yan. The prognostic value of zonal origin in clinically localized prostate cancer: a systematic review and meta-analysis. Frontiers in oncology. 2023, 13: 1248222Cited : 0Read More
- 8)- Kazuki Heishima, Naohiko Aketa, Mizuki Heishima, Asuka Kawachi. Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans. Frontiers in oncology. 2023, 13: 1250766Cited : 0Read More
- 9)- Justin C Brown, Stephanie L E Compton, Jeffrey A Meyerhardt, Guillaume Spielmann, Shengping Yang. The dose-response effect of aerobic exercise on inflammation in colon cancer survivors. Frontiers in oncology. 2023, 13: 1257767Cited : 1Read More
- 10)- Minal Çalışkan, Koichi Tazaki. AI/ML advances in non-small cell lung cancer biomarker discovery. Frontiers in oncology. 2023, 13: 1260374Cited : 2Read More
- 11)- Johnny Kao, Michelle Sahagian, Vani Gupta, Symeon Missios, Ashish Sangal. Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases. Frontiers in oncology. 2023, 13: 1267626Cited : 0Read More
- 12)- Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F Baumert, Joachim Lupberger. Inflammation-related prognostic markers in resected hepatocellular carcinoma. Frontiers in oncology. 2023, 13: 1267870Cited : 6Read More
- 13)- Grzegorz Młynarczyk, Natalia Domian, Irena Kasacka. Changes in adhesion molecules: β-catenin, E-cadherin and Galectin-3 in cells of testicular seminoma. Frontiers in oncology. 2023, 13: 1269637Cited : 0Read More
- 14)- Jacob A Ford, Arjun Bhatt, Rachel C Kim, Michael Larkins, Aidan M Burke. Primary squamous cell carcinoma of the pancreas: an update on a rare neoplasm from the SEER database. Frontiers in oncology. 2023, 13: 1272740Cited : 1Read More
- 15)- Xunbo Zheng, Li Han, Jun Guan, Chenteng Chen, Yue Zhang, Jiali Zhang, Yiran Zhang, Siyao Liu, Junyan Su, Mengyuan Liu, Hanxing Huang. serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism. Frontiers in oncology. 2023, 13: 1274439Cited : 1Read More
- 16)- Anna Cardellino, Julia R Correll, Mona Martin, Boris Gorsh, Sandhya Sapra, Rakesh Popat. Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study. Frontiers in oncology. 2023, 13: 1274659Cited : 0Read More
- 17)- Mpano Olivier, Ahmed Abu Ryash, Weiwei Yin, YuHui Bao, Qiangyong Zhou, Xi Wang, Guorong Chen, Xiaojian Yan. Case Report: Leiomyosarcoma of the right external iliac artery: a diagnostic-based study on a rare case. Frontiers in oncology. 2023, 13: 1274694Cited : 0Read More
- 18)- Simona Esposito, Emilia Ruggiero, Augusto Di Castelnuovo, Simona Costanzo, Marialaura Bonaccio, Francesca Bracone, Vincenzo Esposito, Gualtiero Innocenzi, Sergio Paolini, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano, Licia Iacoviello, Alessandro Gialluisi. Identifying brain tumor patients' subtypes based on pre-diagnostic history and clinical characteristics: a pilot hierarchical clustering and association analysis. Frontiers in oncology. 2023, 13: 1276253Cited : 0Read More
- 19)- Sai Man Cheung, Wing-Shan Wu, Nicholas Senn, Ravi Sharma, Trevor McGoldrick, Tanja Gagliardi, Ehab Husain, Yazan Masannat, Jiabao He. Towards detection of early response in neoadjuvant chemotherapy of breast cancer using Bayesian intravoxel incoherent motion. Frontiers in oncology. 2023, 13: 1277556Cited : 1Read More
- 20)- Tirion Hughes, Anna M Rose. The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic mutations. Frontiers in oncology. 2023, 13: 1278004Cited : 0Read More
- 21)- Rui Chen, Yuncai Ran, Haowen Xu, Junxia Niu, Mengzhu Wang, Yanglei Wu, Yong Zhang, Jingliang Cheng. The guiding value of the cinematic volume rendering technique in the preoperative diagnosis of brachial plexus schwannoma. Frontiers in oncology. 2023, 13: 1278386Cited : 1Read More
- 22)- Jiro Ichikawa, Tomonori Kawasaki, Hiroki Imada, Masanori Wako, Taro Fujimaki, Rikito Tatsuno, Takahiro Jubashi, Hirotaka Haro. Case Report: Angiomatoid fibrous histiocytoma in the hand: a rare clinical presentation and diagnostic challenge. Frontiers in oncology. 2023, 13: 1280630Cited : 1Read More
- 23)- Franziska Siegel, Hannes Schmidt, Manisha Juneja, Janice Smith, Pia Herrmann, Dennis Kobelt, Kamal Sharma, Iduna Fichtner, Wolfgang Walther, Gunnar Dittmar, Rudolf Volkmer, Fritz G Rathjen, Peter M Schlag, Ulrike Stein. GIPC1 regulates MACC1-driven metastasis. Frontiers in oncology. 2023, 13: 1280977Cited : 0Read More
- 24)- Justin B Hackett, Nicholas Ramos, Stephen Barr, Madeline Bross, Nerissa T Viola, Heather M Gibson. Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors. Frontiers in oncology. 2023, 13: 1285117Cited : 1Read More
- 25)- Sukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges. Frontiers in oncology. 2023, 13: 1286104Cited : 2Read More
- 26)- Guangyao Lin, Huicong Liu, Jingyu Lin, Xiyu Liu, Lianwei Xu. Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis. Frontiers in oncology. 2023, 13: 1286610Cited : 2Read More
- 27)- Laura Tascón Padrón, Eva K Egger, Damian Johannes Ralser, Lucia Otten, Özer-Altan Toksöz, Glen Kristiansen, Walter Stummer, Alexander Mustea. Optimized complete cytoreduction in ovarian cancer through intraoperative real-time tumor visualization by 5-ALA - a case report. Frontiers in oncology. 2023, 13: 1288775Cited : 0Read More
- 28)- Xin-Yuan Yu, Yu-Qin Zhu, Xin Liu, Rong Tian, Jun-Jie Chen, Guo-Qing Liu, Dong-Yu Yang, Xue-Ping Zhang, Bao Li, Hong-Jun Zhao, Xiao Li. Case report: 177Lu DOTA-TATE: a new scheme for the treatment of prostate neuroendocrine cancer. Frontiers in oncology. 2023, 13: 1289272Cited : 0Read More
- 29)- Miriam R Brezis, Eliya Shachar, Shira Peleg Hasson, Ido Laskov, Nadav Michaan, Bar Levy, Ido Wolf, Tamar Safra. Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen. Frontiers in oncology. 2023, 13: 1289379Cited : 0Read More
- 30)- Luobin Lin, Yuntao Zhao, Qinzhou Zheng, Jiayang Zhang, Huaqin Li, Wenmei Wu. Epigenetic targeting of autophagy for cancer: DNA and RNA methylation. Frontiers in oncology. 2023, 13: 1290330Cited : 2Read More
- 31)- Wenli Gan, Ce Bian. The research progress on synchronous endometrial and ovarian carcinoma. Frontiers in oncology. 2023, 13: 1291602Cited : 2Read More
- 32)- Fabian Tollens, Pascal A T Baltzer, Matthias F Froelich, Clemens G Kaiser. Economic evaluation of breast MRI in screening - a systematic review and basic approach to cost-effectiveness analyses. Frontiers in oncology. 2023, 13: 1292268Cited : 1Read More
- 33)- Daniel V Runco, Linda A DiMeglio, Charles P Vanderpool, Yan Han, Joanne Daggy, Mary M Kelley, Raya Mikesell, Teresa A Zimmers. Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer. Frontiers in oncology. 2023, 13: 1295228Cited : 1Read More
- 34)- Zhichun Wang, Lin Hua, Xiaofeng Liu, Xueli Chen, Guohui Xue. A hematological parameter-based model for distinguishing non-puerperal mastitis from invasive ductal carcinoma. Frontiers in oncology. 2023, 13: 1295656Cited : 0Read More
- 35)- Daniele Lavacchi, Simone Polvani, Antonio Taddei, Federico Scolari, Luca Messerini, Enrico Caliman, Luca Moraldi, Alessia Guidolin, Gian Luca Grazi, Andrea Galli, Serena Pillozzi, Lorenzo Antonuzzo. KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients. Frontiers in oncology. 2023, 13: 1295936Cited : 1Read More
- 36)- Jie Hu, Qilong Liu, Bi Feng, Yanling Lu, Kai Chen. Deciphering the Hypoxia-immune interface in esophageal squamous carcinoma: a prognostic network model. Frontiers in oncology. 2023, 13: 1296814Cited : 0Read More
- 37)- Carlos Fernandez-Llatas, Roberto Gatta, Fernando Seoane, Vincenzo Valentini. Editorial: Artificial intelligence in process modelling in oncology. Frontiers in oncology. 2023, 13: 1298446Cited : 0Read More
- 38)- Małgorzata Wierzbicka, Jarosław Markowski, Wioletta Pietruszewska, Paweł Burduk, Bogusław Mikaszewski, Marek Rogowski, Krzysztof Składowski, Piotr Milecki, Jacek Fijuth, Dariusz Jurkiewicz, Kazimierz Niemczyk, Adam Maciejczyk. Algorithms of follow-up in patients with head and neck cancer in relation to primary location and advancement. Consensus of Polish ENT Society Board and Head Neck Experts. Frontiers in oncology. 2023, 13: 1298541Cited : 1Read More
- 39)- Patrick Nylund, Berta Garrido-Zabala, Antonia Kalushkova, Helena Jernberg Wiklund. The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma. Frontiers in oncology. 2023, 13: 1303677Cited : 1Read More
- 40)- Guangchun Liu, Shenglin Zhang, Ruoyan Lin, Xudong Cao, Lihong Yuan. Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis. Frontiers in oncology. 2023, 13: 1307838Cited : 1Read More
- 41)- . Expression of concern: MRE11 and UBR5 co-operate to suppress RNF168-mediated fusion of dysfunctional telomeres. Frontiers in oncology. 2023, 13: 1308554Cited : 0Read More
- 42)- Liang Wang, Fangzhou Qiu, Yongming Shen, Sen Chen, Ping Si. Co-existence of :: fusion and variant in a pediatric case with acute myeloid leukemia: a case report and literature review. Frontiers in oncology. 2023, 13: 1308786Cited : 0Read More
- 43)- Domenico Ribatti, Tiziana Annese, Roberto Tamma. Vascular co-option in resistance to anti-angiogenic therapy. Frontiers in oncology. 2023, 13: 1323350Cited : 1Read More
- 44)- Minghuang Chen, Weiya Kong, Bin Li, Zongmei Tian, Cong Yin, Meng Zhang, Haixia Pan, Wenpei Bai. Revolutionizing hysteroscopy outcomes: AI-powered uterine myoma diagnosis algorithm shortens operation time and reduces blood loss. Frontiers in oncology. 2023, 13: 1325179Cited : 1Read More
- 45)- Jiyu Tang, Nan Yang, Shujun Pan, Peiyao Ren, Maosheng Chen, Juan Jin, Qiang He, Yuqun Zeng. The renal damage and mechanisms relevant to antitumoral drugs. Frontiers in oncology. 2023, 13: 1331671Cited : 1Read More
- 46)- Hui Zhang, Yongfu Guan, Jinping Chen, Wenting Tong. Corrigendum: Commentary: AI-based online chat and the future of oncology care: a promising technology or a solution in search of a problem? Frontiers in oncology. 2023, 13: 1334176Cited : 1Read More
- 47)- . Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin. Frontiers in oncology. 2023, 13: 1337635Cited : 0Read More
- 48)- . Erratum: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Frontiers in oncology. 2023, 13: 1339187Cited : 0Read More
- 49)- . Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics. Frontiers in oncology. 2023, 13: 1343833Cited : 0Read More
- 50)- Xiao-Han Zhao, Wen-Bin Shen, Duo Wang, He-Song Wang, Chun-Yang Song, Wen-Zhao Deng. Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy. Frontiers in oncology. 2023, 13: 1347301Cited : 2Read More
